Jerusalem Pharmaceuticals Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
LLY | Eli Lilly and | Outperform |
16
|
$776.75 | $636.99 | 12.97% | 9 | $699.39B |
JNJ | Johnson & Johnson | Outperform |
9
|
$151.18 | $174.55 | 12.45% | 3 | $364.31B |
MRK | Merck | Outperform |
2
|
$128.80 | $130.51 | 11.02% | 11 | $326.25B |
AZN | AstraZeneca PLC | Outperform |
17
|
£121.70 | £165.99 | 33.89% | 16 | £188.66B |
PFE | Pfizer | Outperform |
2
|
$27.18 | $32.87 | 12.21% | 6 | $153.91B |
VRTX | Vertex Pharmaceuticals Inc | Outperform |
12
|
$402.14 | $457.59 | 11.90% | 11 | $103.94B |
REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$903.48 | $961.26 | 16.22% | 8 | $97.47B |
BMY | Bristol-Myers Squibb | Hold |
2
|
$44.21 | $58.15 | 22.14% | 10 | $89.62B |
GSK | GSK | Outperform |
12
|
£17.05 | £17.30 | 14.37% | 12 | £69.53B |
ZTS | Zoetis | Outperform |
18
|
$158.50 | $220.47 | 39.43% | 5 | $72.43B |
MRK | Merck KGaA | Outperform |
18
|
148.95€ | 190.06€ | 22.86% | 4 | 64.76€B |
AGN | Allergan | - |
0
|
$47.83 | $193.25 | -100.00% | 0 | $63.79B |
BAX | Baxter International Inc | Outperform |
17
|
$40.34 | $44.86 | 11.55% | 5 | $20.55B |
ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$149.96 | $245.24 | 43.37% | 7 | $18.96B |
VTRS | Viatris Inc | Hold |
8
|
$11.63 | $11.73 | 3.18% | 5 | $13.74B |
UTHR | United Therapeutics | Outperform |
12
|
$255.14 | $284.08 | 16.41% | 3 | $11.32B |
CTLT | Catalent | Hold |
15
|
$56.00 | $49.29 | 13.39% | 3 | $10.11B |
IPN | Ipsen | Hold |
17
|
114.10€ | 127.95€ | 5.17% | 0 | 9.42€B |
CYTK | Cytokinetics | Outperform |
10
|
$63.37 | $87.92 | 48.34% | 11 | $6.42B |
IONS | Ionis Pharmaceuticals | Outperform |
9
|
$43.01 | $55.60 | 39.97% | 3 | $6.02B |
DPH | Dechra Pharmaceuticals PLC | - |
18
|
£38.66 | £39.86 | -100.00% | 4 | £4.40B |
HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.35 | £28.11 | 50.96% | 9 | £4.27B |
BCPC | Balchem | Outperform |
18
|
$143.82 | $145.00 | 10.90% | 1 | $4.56B |
PRGO | Perrigo Co PLC | Buy |
16
|
$32.90 | $44.75 | 20.36% | 0 | $4.43B |
BHC | Bausch Health Companies | Hold |
15
|
$8.75 | $9.50 | 8.57% | 5 | $3.21B |
NEOG | Neogen | Outperform |
16
|
$12.25 | $37.00 | 38.78% | 0 | $2.67B |
INDV | Indivior PLC | Buy |
14
|
£14.28 | £28.89 | 118.77% | 4 | £1.95B |
AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$42.08 | $69.00 | 47.34% | 0 | $2.02B |
TGTX | TG Therapeutics | Outperform |
9
|
$15.88 | $29.44 | 145.59% | 6 | $1.98B |
CPRX | Catalyst Pharmaceuticals | Buy |
16
|
$15.20 | $26.20 | 71.05% | 2 | $1.78B |
SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$30.08 | $41.00 | 32.98% | 0 | $1.65B |
CLIN | Clinigen | - |
18
|
£9.25 | £7.78 | -100.00% | 0 | £1.23B |
ANIP | ANI Pharmaceuticals | Buy |
13
|
$66.52 | $69.75 | 20.26% | 1 | $1.38B |
LGND | Ligand Pharmaceuticals | Outperform |
14
|
$71.42 | $111.83 | 54.02% | 3 | $1.26B |
VRNA | Verona Pharma | Buy |
4
|
$15.22 | $33.14 | 123.39% | 2 | $1.25B |
VEC | Vectura Group | - |
14
|
£165.00 | £1.55 | -100.00% | 0 | £1.00B |
IRWD | Ironwood Pharmaceuticals | Buy |
14
|
$8.22 | $17.83 | 106.81% | 2 | $1.23B |
PCRX | Pacira BioSciences | Outperform |
16
|
$26.95 | $47.90 | 66.98% | 6 | $1.22B |
COLL | Collegium Pharmaceutical | Outperform |
11
|
$37.78 | $37.75 | 5.88% | 1 | $1.21B |
BIOG B | BioGaia AB (publ) | Buy |
18
|
kr117.90 | kr140.00 | 18.74% | 0 | kr11.91B |
SAVA | Cassava Sciences | Outperform |
8
|
$22.14 | $124.00 | 349.41% | 1 | $957.89M |
ATRS | Antares Pharma | - |
8
|
$5.59 | $5.60 | 16.46% | 0 | $955.07M |
INVA | Innoviva | Hold |
16
|
$15.23 | $15.00 | -1.51% | 1 | $944.65M |
USNA | USANA Health Sciences | Hold |
14
|
$45.55 | $104.00 | 24.04% | 1 | $798.87M |
BSTC | BioSpecifics Technologies | - |
14
|
$0.00 | $88.50 | 0.00% | 0 | $647.97M |
BOI | Boiron | Outperform |
16
|
34.30€ | 43.93€ | 15.45% | 2 | 595.52€M |
BDSI | BioDelivery Sciences Internati... | - |
11
|
$5.59 | $10.00 | 16.46% | 0 | $577.05M |
ADMS | Adamas Pharmaceuticals | - |
7
|
$8.22 | $8.52 | -100.00% | 3 | $376.37M |
ESPR | Esperion Therapeutics | Outperform |
10
|
$2.04 | $8.19 | 292.16% | 1 | $373.12M |
AERI | Aerie Pharmaceuticals | - |
7
|
$0.73 | $15.25 | -100.00% | 0 | $358.35M |
ZVRA | Zevra Therapeutics | Buy |
10
|
$4.60 | $19.50 | 302.17% | 1 | $253.06M |
APH | Alliance Pharma | Outperform |
18
|
£0.34 | £0.82 | 76.47% | 2 | £191.84M |
RCEL | AVITA Medical | Buy |
6
|
$8.65 | $37.39 | 290.98% | 6 | $222.91M |
ATOS | Atossa Genetics Inc | Buy |
5
|
$1.53 | $4.83 | 161.44% | 0 | $219.28M |
AVM | AMAG Pharmaceuticals | - |
2
|
$314.00 | $13.75 | -100.00% | 0 | $211.76M |
ALSEN | Sensorion | Buy |
6
|
0.70€ | 2.33€ | 257.14% | 1 | 196.71€M |
ALIM | Alimera Sciences | Buy |
9
|
$3.46 | $7.00 | 131.21% | 3 | $185.33M |
RIGL | Rigel Pharmaceuticals | Outperform |
4
|
$1.09 | $4.04 | 129.36% | 3 | $184.15M |
NKTR | Nektar Therapeutics | Hold |
11
|
$1.65 | $2.75 | -39.39% | 2 | $171.69M |
PRTK | Paratek Pharmaceuticals | - |
2
|
$2.21 | $2.15 | -100.00% | 2 | $143.19M |
KPTI | Karyopharm Therapeutics | Outperform |
6
|
$1.08 | $6.00 | 362.96% | 1 | $134.63M |
FUM | Futura Medical | Buy |
4
|
£0.33 | £1.26 | 278.79% | 1 | £107.47M |
SCTL | Societal CDMO | - |
9
|
$1.10 | $1.86 | -100.00% | 1 | $116.26M |
AGEN | Agenus | Buy |
8
|
$13.26 | $6.67 | 503.32% | 2 | $111.22M |
AB | AB Science | Buy |
6
|
1.92€ | 10.00€ | 259.38% | 0 | 97.95€M |
MSON B | Midsona AB (publ) |
14
|
kr8.04 | kr18.00 | -100.00% | 1 | kr1.12B | |
GALT | Galectin Therapeutics | Outperform |
6
|
$1.74 | $11.00 | 532.18% | 0 | $102.05M |
SNSS | Sunesis Pharmaceuticals | - |
2
|
$0.00 | $42.00 | 0.00% | 0 | $96.26M |
ASRT | Assertio Holdings | Buy |
8
|
$0.92 | $3.50 | 226.09% | 2 | $88.49M |
EGRX | Eagle Pharmaceuticals | - |
14
|
$4.19 | $17.00 | -100.00% | 0 | $84.16M |
EAH | ECO Animal Health Group | Buy |
18
|
£1.12 | £1.87 | 48.21% | 1 | £63.68M |
MOB | Moberg Pharma AB (publ) |
7
|
kr34.14 | kr29.00 | -32.63% | 0 | kr858.98M | |
AKN | Akorn Operating Company LLC | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $70.85M |
VLG | Venture Life Group | Buy |
15
|
£0.40 | £0.76 | 90.00% | 0 | £49.33M |
ENV | Enervit S.p.A. | Buy |
9
|
3.18€ | 4.18€ | 30.50% | 0 | 55.18€M |
ENZY | Enzymatica AB (publ) |
8
|
kr3.03 | kr0.47 | -86.47% | 0 | kr612.04M | |
ORX | Orexo AB (publ) |
6
|
kr16.90 | kr25.50 | 36.09% | 0 | kr569.11M | |
SIS | Science in Sport | Buy |
9
|
£0.16 | £0.30 | 87.50% | 0 | £28.39M |
CASI | CASI Pharmaceuticals | Outperform |
2
|
$2.39 | $12.00 | 402.09% | 1 | $33.77M |
NLTX | Neoleukin Therapeutics | - |
6
|
$13.96 | $21.57 | -100.00% | 0 | $31.01M |
DRRX | DURECT | Outperform |
9
|
$0.97 | $6.75 | 595.88% | 2 | $28.93M |
TXMD | TherapeuticsMD | - |
5
|
$2.26 | $5.00 | 3.10% | 0 | $27.14M |
LCI | Lannett Company | - |
10
|
$0.03 | $4.00 | -100.00% | 1 | $21.85M |
MEIP | MEI Pharma | Outperform |
10
|
$3.06 | $23.33 | 553.59% | 1 | $21.65M |
ACRX | AcelRx Pharmaceuticals | Buy |
6
|
$1.00 | $4.63 | 413.00% | 0 | $21.53M |
ALCOX | Nicox | Outperform |
7
|
0.39€ | 2.00€ | 156.41% | 1 | 18.70€M |
LPCN | Lipocine | Buy |
2
|
$4.01 | $36.33 | 810.22% | 0 | $13.24M |
TOVX | Theriva Biologics | Buy |
2
|
$0.41 | $4.50 | 997.56% | 1 | $8.43M |
NIMU | Nimutan AB (publ) | - |
8
|
kr0.05 | kr0.00 | -100.00% | 0 | kr86.48M |
SNGX | Soligenix | Buy |
6
|
$0.40 | $3.25 | 775.00% | 0 | $7.56M |
KPRX | Kiora Pharmaceuticals | Outperform |
11
|
$0.55 | $12.83 | 445.45% | 2 | $4.86M |
EVOK | Evoke Pharma | Outperform |
6
|
$0.48 | $7.00 | 1358.33% | 1 | $3.97M |
AGRX | Agile Therapeutics | - |
7
|
$0.44 | $8.50 | -100.00% | 0 | $2.61M |
LIDDS | LIDDS AB (publ) | - |
5
|
kr0.17 | kr4.30 | -100.00% | 0 | kr11.16M |
ZSAN.Q | Zosano Pharma | - |
6
|
$0.00 | $1.00 | 0.00% | 0 | $0.50M |
DMK | DMK Pharmaceuticals | - |
8
|
$0.03 | $1.50 | -100.00% | 0 | $0.35M |
IG | Teligent | - |
2
|
$0.00 | $1.00 | 0.00% | 0 | $0.02M |
ZGNX | Zogenix | - |
0
|
$0.00 | $27.00 | 0.00% | 0 | $0.00M |
FLXN | Flexion Therapeutics | - |
0
|
$9.25 | $10.00 | -100.00% | 0 | $0.00M |
INFI.Q | Infinity Pharmaceuticals | - |
7
|
$0.00 | $0.30 | 0.00% | 1 | $0.00M |